pituitary gland at the tumor's posterior margin, facilitating an extracapsular resection of the adenoma. We sought to investigate whether the use of this surgical plane improves resection of larger macroadenomas and decreases the incidence of residual tumor observed on postoperative imaging.
Surgical Technique
The surgery begins with one of the conventional approaches to the anterior face of the sella using the operating microscope or the endoscope. The bone covering the anterior and inferior surfaces of the sella is removed to expose the medial portion of the anterior face of the cavernous sinus on each side and to reach the tuberculum sellae superiorly. The dura mater is opened widely while attempting to leave the anterior surface of the pituitary (the pituitary capsule) intact.
The anterior surface of the pituitary is inspected to identify any region of compressed normal gland at the periphery of the adenoma superiorly and laterally. If a thin rim of gland is identified, a very superficial incision is made through the normal gland just before the junction of the effaced normal gland and the adenoma (this incision is very superficial, as even the most superficial incision will expose the interface between the pseudocapsule of the tumor and the compressed normal gland; see Video 2). This interface is then dissected gently with the tips of the bipolar forceps or a disc dissector. In general, with large macroadenomas (> 15 mm), this dissection can proceed only a few millimeters along the anterior margins, but often no normal gland is evident at the anterior surface of the tumor at all. In these tumors, and in tumors in which a thin layer of the compressed normal gland is identified and initially dissected, a circular incision is then made in the central portion of the anterior face of the tumor inferiorly, and the central portion of the tumor is removed while leaving a peripheral margin that is thick enough to provide adequate integrity to the dissection plane and permit the development of the pseudocapsule plane around the entire adenoma. Given that removal of the central inferior aspect of the tumor proceeds posteriorly, the surgeon seeks to identify and define the posterior margin of the tumor at the anterior surface of the posteriorly compressed normal gland and develop the distinct interface between these tissues (the pseudocapsule along the posterior edge of the tumor); it is this interface that will be used as the plane of dissection ( Fig. 1A ; Video 1-0:30 and Video 2-1:23). The pseudocapsule is then developed with precise surgical dissection, moving from smaller disc dissectors to progressively larger-diameter ring curettes. During the initial phases of the dissection, no attempt is made to remove tumor or to pull it forward. Instead, the focus is to separate as much of the posterior and posterolateral surface of the tumor from the compressed normal gland and cavernous sinus wall as possible.
A ring curette is then used to continue the sweep of the dissection laterally (at either the 9 o'clock or 3 o'clock position) and anterolaterally around the posterolateral margin of the tumor. The tip of the instrument will have a tendency to remain within the previously developed tissue plane between the tumor and the compressed normal gland. The lateral and inferior components of the tumor are then removed using ring dissection from posterior to anterior while keeping the ring in the tissue plane of dissection ( Fig. 1B ; Video 1-1:14 and Video 2-1:48). In most cases, the lateral dissection is initially done on the side opposite the compressed normal gland, which is usually evident after careful inspection of the MRI studies. After this, tumor along the contralateral inferolateral margin (that which is abutting the pituitary gland) is then removed.
At this stage, much of the tumor within the sella and below the superior plane of the sella has been removed. The surgeon now endeavors to define the tissue plane between the tumor and the compressed gland along the superolateral and superior margins, usually on the side to which the gland has been displaced, typically beginning with a small disc dissector and then progressing to a larger dissector. With each stroke, the sweep of the tip of the instrument extends farther rostrally and begins to turn medially along the lateral aspect of the top margin of the tumor ( Fig. 1C ; Video 1-2:07 and Video 2-2:25).
At this point the pCO 2 is permitted to rise to 50 mm Hg. After 15-30 seconds, the resultant rise in intracranial pressure begins to deliver the tumor into the sella from above. Dissection proceeds in the visible tissue plane along the superior margin of the tumor. Progressively larger ring curettes are used within the tissue plane until the dissection proceeds across the tumor to the opposite side. By this stage, the distinct tissue plane between the surface of the tumor and the compressed normal gland against the diaphragma sellae is visible, and the dissection can often be done under direct vision with the tips of the bipolar forceps or a disc dissector (Fig. 1D) . In larger tumors, the anesthesiologist may provide forced inspiration to 40 mm Hg to inferiorly displace any suprasellar component for final dissection of the superior margin of the tumor and the final stages of tumor removal. Closure is performed according to the surgeon's general preference. Application and utilization of this technique is demonstrated using either the microscope (Video 1) or endoscope (Video 2).
Methods
After receiving IRB approval, we collected the data for this study from prospectively entered presurgical imaging and operative data and retrospectively reviewed postoperative imaging and endocrine evaluation of all patients who, between 2008 and 2015, underwent microscopic sublabial, transsphenoidal resection of a pituitary adenoma performed by a single neurosurgeon (E.H.O.). Inclusion criteria required noncystic pituitary adenomas measuring 20-40 mm in largest diameter (n = 118). Patients were excluded if their preoperative or postoperative imaging records were unavailable (n = 10). Following application of inclusion and exclusion criteria, 108 patients were available for analysis.
Preoperative images were reviewed prior to surgery by the senior author (E.H.O.) for evidence of cavernous sinus invasion, and the tumors were prospectively classified as intrasellar or invasive based on his interpretation. Surgical reports detailing the estimated extent of resection, presence of cavernous sinus invasion identified at surgery, and occurrence of intraoperative CSF leakage were prospectively entered into a database by the senior author shortly after surgery.
In this study, patients were classified according to operative technique. Patients in Group A underwent resection of a macroadenoma before introduction of the pseudocapsule technique (before July 2010). Patients in Group B underwent resection via the posterior pseudocapsule technique (July 2010 to November 2015).
A chart review of postoperative radiology reports and endocrine follow-up was then performed to determine the presence and location of any residual tumor at 2 months, the incidence of new-onset endocrine deficits, and the recovery of prior pituitary deficiencies at the last follow-up. We reviewed images obtained in all patients with residual tumor to determine the location (intrasellar or within the cavernous sinus) of the residual tumor. Images were then retrospectively reviewed by the first author (D.G.T.) to determine Knosp classification, 11 and tumors were classified accordingly.
New pituitary deficits were determined based on 1) new laboratory deficiencies or 2) treatment with new supplemental medications without previously documented deficiencies or supplemental medications. Patients with preoperative panhypopituitarism (n = 11) were excluded from evaluation of new-onset deficits after surgery.
Patients with a prior abnormal pituitary deficit that returned to normal during follow-up or those previously receiving supplemental medications that were subsequently discontinued at follow-up were considered to have recovered from a preoperative pituitary deficiency. Patients without preoperative endocrine deficits (n = 34) were ex- cluded from analysis of the recovery of deficits. Two patients were not included in analysis of endocrine recovery: one due to inadequate laboratory follow-up and the other due to concurrent androgen suppression treatment for prostate cancer in the setting of a testosterone deficiency.
The presence of residual tumor on postoperative MRI, the extent of resection estimated at surgery, intraoperative CSF leakage, and new-onset endocrine deficits were compared between Groups A and B in patients with and without cavernous sinus invasion. Statistical analysis was performed using the chi-square test for categorical outcomes.
Results
There were 34 patients in Group A and 74 in Group B. Tumors in 16 (47%) Group A and 34 (46%) Group B patients had evidence of cavernous sinus invasion on preoperative MRI (p = 0.874). Fourteen (44%) Group A patients and 25 (35%) Group B patients had Knosp grades of 3 or 4 (p = 0.413). At surgery, 12 (38%) Group A and 38 (51%) Group B patients had evidence of cavernous sinus invasion (p = 0.152). There were no differences in the incidence of prior surgery (p = 0.1), time to imaging follow-up (p = 0.9), time to endocrine follow-up (p = 0.5), size of tumor (p = 0.3), incidence of preoperative endocrine deficits (0.896), or tumor type (Table 1) .
Among tumors without evidence of cavernous sinus invasion on prospective preoperative MRI evaluation or those with retrospective Knosp grades of 1 or 2, the incidence of residual tumor on postoperative imaging was reduced when the posterior pseudocapsular technique (Group B) was used (10% [Group B] vs 39%, p < 0.05; and 15% [Group B] vs 39%, p < 0.05, respectively). Moreover, when there was no evidence of cavernous sinus invasion at surgery, residual tumor was again less likely among Group B patients (9% vs 50%, p < 0.05). Furthermore, when limited to the intrasellar component of all tumors (including those with cavernous sinus invasion), use of the posterior pseudocapsule technique resulted in reduced incidence of residual tumor (18% [Group B] vs 50%, p < 0.005) ( Table 2) .
There was a trend toward significance in the rate of postoperative endocrine deficits between Group A and Group B patients (25% vs 12%, p = 0.098), but this was not statistically significant. There was no difference in the rate of recovery of previous deficits (13% vs 27%, p = 0.199). Intraoperative CSF leakage was less likely in Group B patients (22% vs 38%, p = 0.07), but use of an intraoperative lumbar drain was more frequent in this group (73% vs 30%, p < 0.005) ( Table 1) . When controlling for use of intraoperative lumbar drain, there was no difference between techniques in the rate of intraoperative CSF leakage among patients with (0% vs 17%, p = 0.164) and without (54% vs 35%, p = 0.204) an intraoperative lumbar drain (Table 3) .
Discussion
Pituitary adenomas arise from a single cell within the anterior pituitary. While the adenoma lacks the typical reticulin-supported acinar structure of the normal gland (contributing to the tumor's often suckable and soft nature), tumor growth leads to compression of the adjacent normal gland and its acinar structure and reticulin microskeleton, resulting in a surgical pseudocapsule that encases the entire adenoma and separates it from the normal gland.
In 1936, Costello demonstrated the presence of 225 adenomas among 1000 pituitary glands examined at autopsy. 5 Many of the tumors he described were notable for a boundary of a thin layer of compressed reticulin, the histological pseudocapsule, which was quite distinct from the pituitary capsule derived from the pia mater as CSI = cavernous sinus invasion; DI = diabetes insipidus; GH = growth hormone; NFA = nonfunctioning adenoma; TSH = thyroid-stimulating hormone. * Data were missing for 4 patients (2 patients in each group).
described by Ciric. 3 In the mid-1980s, the senior author (E.H.O.) consistently began removing adenomas using the dissection of the pseudocapsule as a surgical capsule, and, in 2005, Kawamata et al. described the importance of including the pseudocapsule in the excision of growth hormone-secreting tumors for improved endocrine remission of growth hormone-producing tumors. 9, 16 Use of the histological pseudocapsule as a surgical capsule has been previously demonstrated to improve grosstotal resection, remission rates, and rate of tumor recurrence, as well as to improve the resolution of preoperative endocrinopathies among microadenomas. 8, 9, 14, 18 Utilization of the pseudocapsule among macroadenomas, however, has been discussed only in limited series and with little to no emphasis on surgical technique and with contrasting conclusions regarding the efficacy of pseudocapsular resection. 12, 19, 23 Instead, traditional resection of macroadenomas, via either an endoscopic or microscopic approach, has typically used a piecemeal resection technique. 1, 6 The piecemeal technique, however, results in reduced visibility of the tumor margins as the tumor is centrally decompressed and the remaining tumor descends and the normal gland expands. Failure to establish a surgical dissection plane (as with the pseudocapsular technique) can obscure the tumor margins and leave behind remnants of isolated tumor, leading to overestimation of the extent of resection and high rates of residual tumor regardless of whether the microscope or endoscope was used. 2, 4, 7, 13, 17, 20 In the current series, 10 (20%) of all intrasellar tumors without evidence of cavernous sinus invasion at surgery and with presumed gross-total resection had residual tumor at follow-up. Of those, 7 tumors were in Group A and 3 were in Group B, resulting in an overestimation of extent of resection in 41% and 9% (p < 0.05), respectively ( Table  2) . These findings are consistent with those in a series by Kim et al. in which piecemeal resection was associated with a significantly lower incidence of gross-total resection than pseudocapsular resection among pituitary adenomas with a Hardy classification of less than 3.
10 As demonstrated here, development of the posterior pseudocapsule establishes a surgical plane and provides a superior opportunity for true gross-total resection and reduces the incidence of residual intrasellar tumor on postoperative imaging in the absence of cavernous sinus invasion (39% vs 10%, p < 0.05 based on preoperative imaging; 50% vs 9%, p < 0.005 based on intraoperative findings); and for any location (extrasellar included) regardless of cavernous sinus invasion (56% vs 34%, p < 0.05; Table 2 ).
By improving gross-total resection rates and extent of resection in tumors with cavernous sinus invasion, repeat surgery and the necessity of postoperative radiation therapy for residual tumor may be avoided, while more complete resection results in improved tumor growth control rates, reduces the postoperative radiation dose, and decreases the risk of cranial nerve dysfunction following postoperative Gamma Knife radiosurgery among nonfunctioning macroadenomas. 22 Among functioning adenomas, reduced postoperative tumor volume may lead to more rapid resolution of endocrinopathy after radiation treatment. 15, 17, 21 In our study, the incidence of new endocrine deficits was much less likely among Group B patients (25% vs 12%) with a strong trend toward significance (p = 0.098), while the rate of recovery of prior deficits was similar between groups (13% vs 27%, p = 0.199), indicating that the development of the posterior pseudocapsule in the resection of macroadenomas is equally as safe with respect to pituitary function as traditional techniques, and the trend toward significance indicates that the posterior pseudocapsule technique may prove to improve the rate of new endocrinopathies in a larger cohort. Combined with the reduced incidence of residual tumor on postoperative imaging, we believe that pseudocapsular resection along the posterior margin of macroadenomas should be considered by both endoscopic and microscopic pituitary surgeons.
Conclusions
Use of the posterior pseudocapsule dissection plane in macroadenomas significantly decreases the incidence of postoperative residual tumor without increasing the risk of intraoperative CSF leakage or postoperative endocrine deficits and provides a similar rate of recovery of prior endocrine deficiencies. This technique is applicable for both the endoscope and the microscope. More complete resection of adenomas may have a significant impact on postoperative management.
